文献速递儿童神经与发育行为

美国注意缺陷多动障碍儿童与青少年治疗全国性描述

A National Description of Treatment among United States Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
PubMed 文献 · J Pediatr · 2017-11-10

基于2014年美国ADHD与抽动障碍诊断治疗调查(2011-2012年全国儿童健康调查的随访调查),分析4-17岁现患ADHD儿童(n=2495)的终生和当前治疗率。结果显示药物和学校支持最常见(各约三分之二当前接受),社会技能训练是最常见心理社会治疗(39%),多数儿童至少接受过两类推荐治疗,7%未接受任何三类治疗。

要点

  • 约三分之二现患ADHD儿童当前接受药物治疗和学校支持。
  • 心理社会干预接受率较低,社会技能训练终生接受率39%。
  • 7%的儿童未接受当前药物、当前学校支持或终生心理社会治疗中的任何一类。

核心结论

  • 多数ADHD学龄儿童接受药物治疗和学校支持,但接受推荐心理社会干预的比例较低。
  • 增加心理社会治疗可及性可能有助于缩小服务使用差距。

研究设计与样本

  • 数据来自2014年全国ADHD与抽动障碍诊断治疗调查,为2011-2012年全国儿童健康调查的随访调查。
  • 加权分析纳入4-17岁现患ADHD儿童2495名,评估4类治疗:药物、学校支持、心理社会干预和替代治疗。

主要发现

  • 药物和学校支持是最常见治疗,约三分之二现患ADHD儿童当前接受每种治疗。
  • 社会技能训练是最常见终生心理社会治疗(39%),其次为家长培训(31%)、同伴干预(30%)和认知行为治疗(20%)。
  • 替代治疗中,9%当前服用膳食补充剂,11%曾接受神经反馈。
  • 67%的儿童至少接受过当前药物、当前学校支持或终生心理社会治疗中的两类,7%未接受任何一类。

关键数值与推荐

  • 社会技能训练终生接受率39%,家长培训31%,同伴干预30%,认知行为治疗20%。
  • 当前膳食补充剂使用率9%,神经反馈终生接受率11%。
  • 67%至少接受两类推荐治疗,7%未接受任何三类推荐治疗。

临床怎么用

  • 临床中应评估ADHD儿童对心理社会干预的可及性,尤其针对当前接受率较低的人群。
  • 药物治疗和学校支持覆盖率较高,但需关注未接受任何推荐治疗的7%儿童。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize lifetime and current rates of attention-deficit/hyperactivity disorder (ADHD) treatments among US children and adolescents with current ADHD and describe the association of these treatments with demographic and clinical factors. STUDY DESIGN: Data are from the 2014 National Survey of the Diagnosis and Treatment of ADHD and Tourette Syndrome, a follow-back survey of parents from the 2011-2012 National Survey of Children's Health. Weighted analyses focused on receipt of ADHD treatment among children aged 4-17 years with current ADHD (n = 2495) by 4 treatment types: medication, school supports, psychosocial interventions, and alternative treatments. RESULTS: Medication and school supports were the most common treatments received, with two-thirds of children and adolescents with ADHD currently receiving each treatment. Social skills training was the most common psychosocial treatment ever received (39%), followed by parent training (31%), peer intervention (30%), and cognitive behavioral therapy (20%). Among alternative treatments, 9% were currently taking dietary supplements, and 11% had ever received neurofeedback. Most children (67%) had received at least 2 of the following: current medication treatment, current school supports, or lifetime psychosocial treatment; 7% had received none of these 3 treatment types. CONCLUSIONS: A majority of school-aged children and adolescents with ADHD received medication treatment and school supports, whereas fewer received recommended psychosocial interventions. Efforts to increase access to psychosocial treatments may help close gaps in service use by groups currently less likely to receive treatment, which is important to ensure that the millions of school-aged US children diagnosed with ADHD receive quality treatment.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Danielson ML, Visser SN, Chronis-Tuscano A, et al. A National Description of Treatment among United States Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. J Pediatr. 2017. PMID: 29132817. doi:10.1016/j.jpeds.2017.08.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。